Company Filing History:
4 out of 129 
3 out of 3 
1 out of 295 
Years Active: 2011-2020
Title: Kypros Nicolaides: Innovator in Maternal and Fetal Health
Introduction
Kypros Nicolaides is a prominent inventor based in London, GB. He has made significant contributions to the field of maternal and fetal health, holding a total of six patents. His work focuses on innovative methods for predicting and assessing health risks during pregnancy.
Latest Patents
One of his latest patents is titled "Metabolomic prediction of congenital heart defect during pregnancy, newborn and pediatric stages." This invention involves methods for assaying metabolite levels in samples from a patient during pregnancy using advanced techniques such as nuclear magnetic resonance and direct flow injection mass spectrometry. The metabolites analyzed include acylcarnitine and various specific compounds like C3-OH, C5-OH, C10, C5:1-DC, C14:1-OH, and C14:2-OH. Additionally, the methods may include measuring nuchal translucency of the fetus to predict congenital heart defects.
Another significant patent relates to "Methods for determining maternal health risks." This invention provides a method for assessing the risk of pregnant women developing hypertensive disorders, including gestational hypertension and preeclampsia. The patent outlines useful combinations of biochemical markers, such as PlGF and Activin A, to determine the risk of multiple hypertensive disorders in a single screening.
Career Highlights
Kypros Nicolaides has had a distinguished career, working with notable organizations such as Wallac Oy and The Fetal Medicine Foundation. His expertise in maternal-fetal medicine has led to groundbreaking advancements in prenatal care.
Collaborations
Throughout his career, Nicolaides has collaborated with esteemed colleagues, including Howard Cuckle and Tarja Ahola. These partnerships have further enhanced his research and contributions to the field.
Conclusion
Kypros Nicolaides is a leading inventor whose work has significantly impacted maternal and fetal health. His innovative patents and collaborations continue to advance the understanding and management of health risks during pregnancy.